-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Chemours, Raises Price Target to $21

Benzinga·05/11/2026 17:08:43
Listen to the news
Morgan Stanley analyst Vincent Andrews maintains Chemours (NYSE:CC) with a Equal-Weight and raises the price target from $17 to $21.